SL-401, A Targeted Therapy Directed to the Interleukin-3 Receptor Present On Leukemia Blasts and Cancer Stem Cells, Is Active As a Single Agent in Patients with Advanced AML


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Konopleva, M; Hogge, DE; Rizzieri, DA; Cirrito, TP; Kornblau, SM; Borthakur, G; Bivins, C; Garcia-Manero, G; Kadia, TM; Ravandi, F; Andreeff, M; Cortes, JE; Hoberman, K; Szarek, M; Rowinsky, E; Bergstein, I; Kantarjian, HM; Frankel, AE

Published Date

  • November 16, 2012

Published In

Volume / Issue

  • 120 / 21

Published By


  • 2

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)

Conference Location

  • Atlanta, GA

Conference Start Date

  • December 8, 2012

Conference End Date

  • December 11, 2012